Article Text
Abstract
Supratentorial diffuse intrinsic low-grade gliomas represent a distinct but heterogenous group of tumours, with the propensity to grow and to differentiate into malignant tumours. They have been historically viewed in the ‘benign’ spectrum of intrinsic brain tumours, so a watch-and-wait policy was often adopted. With recent advances in our understanding of the natural history of these tumours, combined with advances in surgical technique, an aggressive approach is now recommended. Increasing quality evidence of the impact of tumour resection and multicentre trials of adjuvant radiotherapy and chemotherapy have led to a new algorithm for low-grade glioma management. This review aims to outline the emerging evidence that has shifted neuro-oncology practice.
- low-grade glioma
- awake craniotomy
- molecular genetics
- survival
Statistics from Altmetric.com
Linked Articles
- Editors’ commentary
Read the full text or download the PDF:
Other content recommended for you
- Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution
- Imaging in low-grade glioma: a guide for neurologists
- Low-grade brain tumours and seizures
- The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort study
- Long term reshaping of language, sensory, and motor maps after glioma resection: a new parameter to integrate in the surgical strategy
- Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide
- Clinical importance of molecular markers of adult diffuse glioma
- The dilemma of low grade glioma
- A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up
- Spatial reorganisation of the somatosensory cortex in a patient with a low-grade glioma